Extendicare (TSE:EXE) Price Target Raised to C$9.00

Extendicare (TSE:EXEGet Free Report) had its price objective raised by analysts at TD Securities from C$8.00 to C$9.00 in a research report issued to clients and investors on Wednesday, BayStreet.CA reports. The firm currently has a “hold” rating on the stock. TD Securities’ target price would indicate a potential upside of 9.49% from the company’s previous close.

Separately, Royal Bank of Canada raised their target price on Extendicare from C$8.00 to C$8.50 and gave the company a “sector perform” rating in a report on Tuesday, May 21st.

View Our Latest Stock Analysis on EXE

Extendicare Stock Performance

EXE traded up C$0.09 during trading on Wednesday, hitting C$8.22. The stock had a trading volume of 250,312 shares, compared to its average volume of 124,231. Extendicare has a one year low of C$5.75 and a one year high of C$8.30. The company has a debt-to-equity ratio of 365.69, a current ratio of 0.82 and a quick ratio of 0.98. The firm has a market cap of C$685.38 million, a price-to-earnings ratio of 20.07 and a beta of 1.26. The company has a 50 day moving average price of C$7.45 and a 200-day moving average price of C$7.35.

Extendicare (TSE:EXEGet Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported C$0.29 earnings per share (EPS) for the quarter. The business had revenue of C$348.48 million for the quarter, compared to the consensus estimate of C$360.20 million. Extendicare had a return on equity of 37.03% and a net margin of 2.63%. As a group, research analysts predict that Extendicare will post 0.4699088 EPS for the current year.

About Extendicare

(Get Free Report)

Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.

See Also

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.